Why cost-of-illness studies are important and inform policy

Vascular Medicine

Volumn 13, Issue 3, 2008, Pages 251-253

  Durand Zaleski, Isabelle ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY DISEASE; CARDIOVASCULAR DISEASE; COST OF ILLNESS; EDITORIAL; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH INSURANCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; RESOURCE MANAGEMENT; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; MANAGEMENT; ORGANIZATION AND MANAGEMENT; UNITED STATES;

COST OF ILLNESS; DELIVERY OF HEALTH CARE; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; POLICY MAKING; UNITED STATES;

EID: 58149384425     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X08091738     Document Type: Editorial

References (12)

1. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: A replication and update. Health Care Financ Rev 1985; 7: 61-80.
2. Kirschstein R. Disease-specific estimates of direct and indirect cost of illness and NIH support - Fiscal year 2000 update. Washington, DC: National Institutes of Health, Department of Health and Human Services; 2000.
3. Goddard M, Hauck K, Preker A, Smith PC. Priority setting in health - a political economy perspective. Health Economics. Policy and Law 2006; 1: 79-90.
4. Clabaugh G, Ward MM. Cost-of-illness studies in the United States: A systematic review of methodologies used for direct cost. Value Health 2008; 11: 13-21.
5. Aaron HJ. The cost of health care administration in the United States and Canada - questionable answers to a questionable question. N Engl J Med 2003; 349: 801-803.
6. Margolis J, Barron JJ, Grochulski WD. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm 2005; 11: 727-734.
7. Hirsch AT, Hartman L, Town RJ, Virnig BA. National healthcare costs of peripheral arterial disease in the Medicare population. Vasc Med 2008; 13: 209-216.
8. Hodgson TA, Cohen AJ. Medical care expenditures for selected circulatory diseases: Opportunities for reducing national health expenditures. Med Care 1999; 37: 994-1012.
9. Migliaccio-Walle K, Caro JJ, Ishak KJ, O'Brien JA. Costs and medical care consequences associated with the diagnosis of peripheral arterial disease. Pharmacoeconomics 2005; 23: 733-742.
10. Paris, V, Renaud, T, Sermet, C. Des comptes de la santé par pathologie: Un prototype pour l'année 1998. Dossiers solidarité et santé 2003; 2: 1-8.
11. Asaria, P, Chisholm. D, Mathers, C. Ezzati, M, Beaglehole R. Chronic disease prevention: Health effects and financial costs of strategies to reduce salt and control tobacco use. Lancet 2007; 370: 2044-2053.
12. Norgren, L, Hiatt WR, Dormandy, JA, Nehler, MR, Harris KA, Fowkes, FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 (suppl S): S5-S67.